E.g., 09/18/2021
E.g., 09/18/2021

True Direct Quantification of Salmonella Now an AOAC Approved Reality for the Food Industry

31 August, 2021

bioMérieux, Inc. company, obtains AOAC® approval for first-ever enrichment-free Quantification of Salmonella in raw meat and poultry with the GENE-UP® QUANT Salmonella assay.

Labor Day Shipping Schedule

23 August, 2021

Be advised that bioMérieux Inc. sites in Durham, NC, St. Louis, MO, and Lombard, IL will be closed on Monday, September 6, 2021 in observance of the upcoming holiday.

SAS® Viya® Compliments BIOMÉRIEUX’S CLARION™ in Strategic Partnership for Data-Driven AMR Solutions

13 August, 2021

SAS, a leader in global analytics, announced a collaboration with bioMérieux (9 August, 2021) that cultivates a data-driven solution to track and minimize the spread of antimicrobial resistant bacteria.

Independence Day Shipping Schedule

10 June, 2021

Be advised that bioMérieux Inc. sites in Durham, NC, St. Louis, MO, and Lombard, IL will be closed on Monday, July 5, 2021 in observance of the upcoming holiday.

Cannabis Industry Can Now Avoid Costly Recalls with Groundbreaking Scientific Approval

01 June, 2021

bioMérieux, Inc. Awarded First-ever Cannabis-related AOAC Emergency Response Validation for the Enumeration of Yeast & Mold Contamination for its TEMPO® YM Assay

Memorial Day Shipping Schedule

14 May, 2021

Be advised that bioMérieux Inc. sites, Durham, NC, St. Louis, MO, and Lombard, IL will be closed on Monday, May 31st, 2021 in observance of the upcoming holiday.

Spring Holiday Shipping Schedule

26 March, 2021

Be advised that bioMérieux, Inc. sites in Durham, NC, St. Louis, MO, and Lombard, IL will be closed on Friday, April 2, 2021 in observance of the upcoming holiday.

bioMérieux: BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 Obtains De Novo FDA Authorization

18 March, 2021

bioMérieux announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious disease testing, has received U.S. Food and Drug Administration (FDA) De Novo authorization for the BIOFIRE® RP2.1 Panel.

Innovative Technology Mitigates the Risk of Life-Threatening Toxins in Cannabis

24 February, 2021

Invisible Sentinel®, a bioMérieux, Inc. company, obtains the first AOAC® approval for the detection of pathogenic Aspergillus spp. in cannabis.

Cannabis and Hemp are Safer for Consumers with New Microbial Testing Method Validations

26 January, 2021

bioMérieux receives the first AOAC® validation approval for cannabis and hemp.

Pioneering Diagnostics